SHR-4597 Inhalant

SHR-4597 · Guangdong Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-4597 Inhalant, covering 2025-04-23 to 2025-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma [Phase 2]